Medicover AB (publ)
General ticker "MCVEF" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $3.0B (TTM average)
Medicover AB (publ) follows the US Stock Market performance with the rate: 46.7%.
Estimated limits based on current volatility of 0.0%: low 27.25$, high 27.25$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-02, amount 0.18$ (Y0.66%)
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [20.62$, 33.73$]
- 2026-12-31 to 2027-12-31 estimated range: [21.01$, 34.58$]
Financial Metrics affecting the MCVEF estimates:
- Positive: with PPE of 46.0 at the end of fiscal year the price was neutral
- Positive: -4.75 < Operating profit margin, % of 6.55
- Positive: 6.64 < Operating cash flow per share per price, % of 9.84
- Negative: 0.73 < Interest expense per share per price, % of 1.83
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.10
- Positive: 19.40 < Shareholder equity ratio, % of 22.01 <= 42.68
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: -9.07 < Industry operating profit margin (median), % of 0.88
- Positive: Inventory ratio change, % of -0.45 <= 0
Short-term MCVEF quotes
Long-term MCVEF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €1,746.40MM | €2,091.80MM | €2,378.10MM |
| Operating Expenses | €1,685.00MM | €2,021.50MM | €2,222.40MM |
| Operating Income | €61.40MM | €70.30MM | €155.70MM |
| Non-Operating Income | €-37.80MM | €-50.20MM | €-57.30MM |
| Interest Expense | €51.40MM | €60.52MM | €64.00MM |
| R&D Expense | €0.00MM | €7.00MM | €0.00MM |
| Income(Loss) | €23.60MM | €20.10MM | €98.40MM |
| Taxes | €5.20MM | €5.50MM | €25.70MM |
| Profit(Loss)* | €17.60MM | €16.70MM | €77.50MM |
| Stockholders Equity | €496.50MM | €464.80MM | €532.80MM |
| Inventory | €59.40MM | €69.10MM | €67.20MM |
| Assets | €1,941.30MM | €2,138.20MM | €2,420.90MM |
| Operating Cash Flow | €205.00MM | €261.90MM | €343.70MM |
| Capital expenditure | €110.50MM | €122.30MM | €158.10MM |
| Investing Cash Flow | €-119.80MM | €-134.70MM | €-322.10MM |
| Financing Cash Flow | €-73.70MM | €-108.00MM | €-5.80MM |
| Earnings Per Share** | €0.12 | €0.11 | €0.51 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.